학술논문

A SINGLE DOSE STUDY COMPARING PHARMACOKINETICS, SAFETY, AND IMMUNOGENICITY OF M923 (A PROPOSED BIOSIMILAR TO ADALIMUMAB), US-SOURCED ADALIMUMAB, AND EU-SOURCED ADALIMUMAB IN HEALTHY SUBJECTS
Document Type
Journal
Source
ANNALS OF THE RHEUMATIC DISEASES; JUN 2016, 75 p495-p496, 2p. Supplement: 2
Subject
Language
English
ISSN
14682060